Measuring symptomatic benefit and quality of life in paediatric oncology. by Eiser, C. & Jenney, M. E.
Britsh Journal of Cancer (1996) 73, 1313-1316
© 1996 Stockton Press All rights reserved 0007-0920/96 $12.00 $
INVITED EDITORIAL
Measuring symptomatic benefit and quality of life in paediatric oncology
C Eiserl and MEM Jenney2
'Department ofPsychology, University ofExeter, Exeter, EX4 4GQ, Devon UK; 2Oncology/Haematology Directorate, Manchester
Children's Hospital, Pendlebury, Manchester, M27 4HA, UK.
Keywords: quality of life; symptom appraisal
In the early 1960s almost all children with cancer died. If
treatment was offered at all, it was not intensive and the
children could be managed out of hospital except where
supportive care was needed. Over the past three decades the
outlook in terms of survival for these children has
dramatically improved (to overall survival rates of over
60%; Boring et al., 1994). This has been achieved through the
use of national and international trials and, for the majority
of children, a significant increase in intensity of treatment.
Although no-one could question the importance of this
improvement, the intensity of the therapy and its side-effects
can have a significant and often adverse effect on the life of
the child (Stuber et al., 1994). Although survival must not be
compromised, there is an increasing awareness that more
could be done to reduce symptoms and improve quality of
life. Some practical changes in administration of therapy are
welcome. There has been an improvement in the control of
nausea with better anti-emetic therapy. Widespread use of
central venous catheters minimises the need for venepuncture
and in the majority of cases it is now possible to perform
many unpleasant procedures (e.g. bone marrow aspirations
or lumbar punctures) under sedation or general anaesthesia.
Despite these changes, however, there has been increasing
recognition of the potential side-effects of therapy. This
applies to both the short- and longer term. In the short term,
children can experience lengthy hospitalisation, school
absence, broken friendships, hair loss, nausea and mouth
ulcers. Once treatment is over, there may be long-term
problems such as growth impairment and infertility (Shalet,
1989), respiratory (Jenney et al., 1995a) or cardiac damage
(Lipschultz et al., 1991), as well as educational and
psychological problems (Eiser and Havermans, 1994). On
the surface, then, there are many reasons to suppose that
children with cancer might experience a compromised quality
of life. Whereas this is understandable during treatment, it is
sometimes difficult to appreciate that difficulties do not stop
on completion of therapy.
Despite the increased awareness of specific (usually
physical) late effects of therapy, only recently has it been
recognised that there is a need for a measure of patients'
perceptions of the intensity of symptoms associated with
different treatment and consequences for quality of life.
Although this has been addressed by several groups of
researchers in adult patients with cancer (Finkelstein et al.,
1988), it is only recently being appreciated that there is a need
for similar information specific to children.
Why measure quality of life?
As a basisfor interventions
More systematic attention to the determinants of quality of
life in children with cancer is needed as a basis for
appropriate interventions. Work with young people with
diabetes suggests that improvements in self-care can be
achieved when friends are informed and involved in daily
therapy (La Greca, 1990). With few exceptions (Varni and
Setoguchi, 1991), interventions have targeted physical
symptoms at the expense of more social or behavioural
consequences. As issues of importance to the child are
identified, it should be possible to optimise outcomes by
developing more appropriate interventions.
To compare clinical trials
As survival rates have improved there has been a recognition
ofthe need for more sensitive and comprehensive measures of
outcome. Such information may have implications for
planning of future randomised studies. Some changes have
already been made as a consequence of earlier trials. An
example is the omission of cranial irradiation as CNS-
directed therapy in standard risk children with acute
lymphoblastic leukaemia in the latest Medical Research
Council United Kingdom Acute Lymphoblastic Leukaemia
study (UKALL Xl), aiming to reduce the long-term cognitive
or growth impairment that may occur. However, the
situation may not always be so clear. How can we quantify
the impact of a bone marrow transplant on the quality of life
of a child? How does the quality of life of a child with an
amputation compare with that of a child treated with a limb
prosthesis? We may recognise late effects such as infertility,
cataracts or growth impairment but how are these
experienced by children? For them, do the benefits
(extended survival) justify the costs? Accurate measures that
reflect the impact of treatmentfrom the child's perspective are
urgently needed and could become a useful additional
measure of outcome of individual randomised studies.
The need for child-specific measures
Given the number of measures developed for use with adults
with cancer, why do we advocate new measures for work
with children? There are a number of reasons. We cannot
predict the impact of treatment on a child especially as
problems associated with therapy are at least partly
dependent on the age at diagnosis. Younger children have
significant physical problems in the short and long term (poor
nutrition, growth impairment, cognitive impairment following
radiotherapy) as well as emotional problems resulting from
interrupted care-taking and the need for extended hospitalisa-
tion. They also experience difficulties in understanding the
reason for treatment. Older children may experience different
emotional problems resulting from greater embarassement
associated with alopecia, interrupted school attendance and
peer and family problems. While they are more able to
understand the reason for treatment, this in itself may be
distressing information, raising questions about disability or
long-term survival.
The challenge when working with children, however, is to
take into account how concerns change with maturity.
Correspondence: C Eiser
Received 6 November 1995; revised 15 December 1995; accepted 15
December 1995Quality of life in paediatric oncology
C Eiser and MEM Jenney
1314
Central to many definitions of quality of life is the impact of
disease on school or work progress and relationships with
friends. 'Getting on at school' may have a more social
meaning to the young child. The demands of the national
examination system may create more academic concerns for
the adolescent. There are qualitative shifts in patterns of
friendship such that it is more common for older children to
have fewer but more intimate friendships than younger
children. Normative changes of this kind need to be taken
into account. The speed of development means that concerns
about illness can also change. Cadman and Goldsmith (1986)
found that a scale that was appropriate for 3 year old
children was less adequate for 5 year olds. Thus, any measure
of impact needs to be sensitive to normative developmental
tasks and goals.
Methodological problems
Parent completed measures
In the past, there has been an assumption that parents are the
most reliable sources of information about a child's well-
being. In many situations, children with cancer may be too
young, or too ill, to be able to answer for themselves. In
these cases, medical staff have no choice but to rely on
information from parents. Yet it is surprising how little
evidence exists to suggest that parents are reliable informants
about their child. Conclusions about the level of stress
experienced by a child are dependent on who is giving the
information. Manne et al. (1992) found that most agreement
was between nurse ratings and behavioural observations, with
lowest levels of agreement between parents and child self-
report. Explanations about lower than expected correlations
between parent and child report have focused on parents'
own anxiety levels, but appear to be dependent on other
factors including age and gender. The real limitation is,
however, that parents' reports reflect their own anxiety about
child health or behaviour over and above more objective
indicators.
We cannot therefore assume that parents' reports will
inevitably match those of their child. Even so, parents may be
quite accurate reporters as far as some situations or
behaviours are concerned. Parents appear accurate in their
reports about 'externalising' or acting out problems. They are
less able to report 'internalising' problems such as anxiety or
sadness (Edelbrock et al., 1986). In addition, they lack direct
information that enables them to make competent ratings
about difficulties the child experiences at school or in
interactions with friends.
Self-ratings
Limitations in cognitive or linguistic skills raise unique
methodological issues and have often been used as an
argument against measuring symptoms or quality of life
directly from children. First, it has often been assumed that
children are less able, or even unable, to locate and identify
pain with any reliability. In addition, they do not always
use the same language as adults. For any child, treatment
for cancer can be very painful. For the youngest, this may
be aggravated by inability to understand the reason for the
pain. Second, the behavior of families appears important in
how children express pain. Parents may influence children
by modelling distress themselves or by differentially
reinforcing inappropriate behaviour. In a series of elegant
studies, Blount et al. (1990) have shown that parents who
communicate anxiety, or repeatedly apologise about the
treatment, reinforce distress behaviour. In contrast, parental
use of distraction has been associated with less child
distress. Although the magnitude of these relationships is
generally small, the implication that child distress can be
influenced by specific parental behaviour has considerable
implication for staff in paediatric oncology.
Concern about both these issues means that children's
distress has often gone unrecognised. However, several recent
studies suggest that it is possible to quantify how young
children experience pain. McGrath and McAlpine (1993) used
structured play and story-telling tasks and concluded that
from 18 months of age children were able to say that a pain
hurts, localise and make efforts to alleviate pain and
recognise pain in someone else. Children at this age are
aware of ways of alleviating pain either through hugs and
kisses or asking for medicine. By 3 or 4 years children can
spontaneously use distraction and report that playing makes
them feel better. The available evidence therefore suggests
that it should be possible, given appropriate instruments, to
assess symptoms or quality of life directly in the majority of
children.
Observational measures
A number of methods have been devised to assess immediate
pain associated with procedures. These include general
measures, such as the Neonatal Facial Action Coding
System (Grunau and Craig, 1987) and the Children's
Hospital of Eastern Ontario Pain Scale, (McGrath et al.,
1995). Within paediatric oncology, the most widely used
system (Jay and Elliott, 1984) includes provision for
continuous behavioural recording in 15 s intervals and a
weighted score of severity of distress for each of 11
behavioural categories assessed. Scores correlate well with
physical parameters but not with child self-reports. Only one
scale has been developed to assess longer lasting pain,
although this is specifically for use with children with cancer
(Gauvin-Piquard et al., 1987).
Measuring symptoms
A number of parent-rated symptom checklists for children
exist, although they tend to include physical symptoms along
with more general behaviour (Achenbach and Edelbrock,
1983; Jellinek and Murphy, 1990). These measures have been
criticised for use with children with physical illness, especially
as they are lengthy and may include physical symptoms that
would inflate scores of a sick child.
Symptom inventories that are specific to cancer have been
developed for work with adults, but may require some
changes to make them appropriate for children with cancer.
If reports are to be elicited from children themselves, care
needs to be taken that the vocabulary used is appropriate for
the age of the child. Although children share adult skills in
identifying simple emotions (such as happy, sad or angry),
fear expressions are more difficult to identify (Wagner et al.,
1986). Adult inventories typically include both physical and
psychological symptoms. Adult symptom inventories include
language that would not be familiar to the child. The
Rotterdam Symptom Inventory (de Haes et al., 1990) for
example asks patients to make ratings regarding 'nausea,
diarrhoea', terms which are not likely to be used by children.
In addition, they may include inappropriate behaviour (e.g.
loss of sexual interest). Psychological symptoms in particular
are likely to have different meanings for children and adults.
Children can confuse 'feeling bored' with depression
(Graham and Hughes, 1995).
The standard paradigm used to assess children's symptoms
tends to include numerical rating scales with descriptive or
pictorial landmarks, colour or visual analogue scales. The
commonly used visual analogue scale has been used
successfully to assess pain in 3 to 12-year-old children
(Beyer and Knapp, 1986). Zeltzer et al. (1988) report some
evidence that children from 6 years of age can reliably use
similar rating scales. A popular alternative involves the use of
faces in place of the traditional numerical rating; (the faces
depict different emotions and are ordered from very sad to
very happy), Zeltzer et al. (1984) reported 80% concordance
between parents and their child on ratings of nausea and
vomiting using faces as signposts along the scale. However,Quality of life in paediatric oncology
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not everyone would agree. Redd et al. (1987) reported that
similar scales were not helpful when working with children
less than 9 years old.
Measuring health and quality of life
Children have very different ideas about the meaning of
health compared with adults. Younger children tend to
describe good health as the ability to perform superman acts,
to be able to run faster than anyone else or be an Olympic
champion. With age, individuals increasingly describe good
health as the ability to perform everyday functions, with the
elderly describing themselves as healthy as long as they
perform basic self-care activities (Millstein and Irwin, 1987).
In practice, workers tend to adopt the WHO definition of
quality of life, which emphasises a state of complete physical,
social and mental well-being, and not merely the absence of
disease or infirmity. Most include an ad hoc selection of items
rather than being based on any theoretically driven under-
standing of quality of life. Certain requirements of any
acceptable measure have also been advocated; a measure
must be brief but comprehensive; reliable and valid, and
include both child and adult ratings (Mulhern et al., 1989). In
practice, some of these requirements may be less appropriate
than others. The argument for a reliable instrument needs to
be balanced against the inevitable change that accompanies
development of any child. In addition, the scale must be
sensitive to fluctuations in the health of the child with cancer.
The search for a highly reliable measure may in fact prove a
red herring.
Recognition of the way in which quality of life in children
with cancer can be compromised has resulted in a number of
measures (for reviews see Eiser, 1995; Jenney et al., 1995b).
There is some variation, however, in the assumed compo-
nents of quality of life. Mulhern et al. (1989) argue that it is
important to make at least three broad distinctions; between
physical function, psychological function and self-satisfac-
tion. In contrast, a larger number of domains are
distinguished by Feeny et al. (1992); including cognition,
mobility, sensation, pain, self-care, fertility and emotion.
Although several measures take adult work as the starting
point, others are based on the results of detailed interviews or
focus groups with young people, in efforts to ensure that the
measures really focus on issues of importance to the child.
While acknowledging that it is possible and advisable to elicit
information directly from children, the need for parallel child
and adult forms is also recognised. This is specially important
in work with very young or sick children of all ages.
A summary of published quality of life scales is shown in
Table I. In selecting a scale, consideration needs to be given
to the purpose of assessment, the time available and whether
or not it is possible to elicit information directly from the
child. Given the recent development of this area, relatively
little reliability or validity data is currently available for any
of the measures. There is an urgent need for large-scale
studies that consider the statistical properties of the scales
and their inter-relationships.
Discussion
In the last few years, real progress has been made in
developing child-based measures of symptom report and
quality of life. With a little creativity, it should be possible to
extend the current measures in order to achieve greater
appropriateness for work with younger children. Even so, it
seems unlikely that, given the current status of measurement
technique, it will be possible to develop methods that are of
acceptable reliability for children below 6 years of age.
Currently available instruments have their own merits. In
addition, they share a number of shortcomings. To date,
there has been no multicentre assessment of alternative
measures that would enable decisions to be taken about the
most appropriate measure for different purposes. Multicentre
collaboration is also needed to determine reliability and
validity. So far, all measures are based in one or two centres
and are therefore necessarily limited to small or hetero-
geneous samples. There also needs to be more discussion
about the kind of measures that are most appropriate to
assess validity.
Although measures of symptomotology or quality of life
have not previously been integrated in evaluations of clinical
trials in paediatric oncology, the availability of measures and
awareness of differences between child and adult perceptions
of the illness experience suggest that they must become so. In
addition, the more routine use of quality of life measures in
the clinic may prove useful as an adjunct to the clinical
interview, and especially valuable with the child or adolescent
who is reluctant to discuss issues more openly.
There has been considerable progress in the extent to
which clinicians now recognise the need for child-based
assessment, with the related acknowledgement that this
cannot be a simple scaling down of adult measures. For the
future, however, there is a need for a more theoretically
based approach to understanding and assessing quality of life
in children with cancer. This may best be achieved by
adopting a wider framework defined by normative develop-
mental psychology.
Table I Cancer-specific quality of life scales for children
Age range
Scale Components Respondents (years) Validity
Play performance None Parents 1-16 Global function
Lansky et al. (1985) Physicians Research interviews
Quality of well-being Mobility Parents 4-18 Play performance
Bradlyn et al. (1993) Physical function Treatment toxicity
Social activity
Symptoms
Multi-attribute health status Mobility Physicians 8-25 Population norms
Feeny et al. (1992) Cognition
Sensation
Pain
Self-care
Fertility
Emotion
Quality of life Physical function Parents Very wide Play performance
Goodwin et al. (1994) Emotional distress Child behaviour
Reaction to treatment Checklist
Depression1316
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